Announcement – EMVO notice of On-boarding on time

The deadline of the implementation of the Falsified Medicines Directive 2011/62/EU and the Delegated Regulation 2016/161 (altogether ‘FMD’) approaches fast. The purpose of the attached Letter of Announcement is to address pharmaceutical companies that haven’t started the on-boarding process to the EU Hub yet and make a notice to on-board on time.

More Details:

Find more detailed information from the Letter of Announcement

2018/08/06 | EMVO notice of On-boarding on time